Pulse Biosciences (PLSE) Assets Average (2016 - 2025)

Pulse Biosciences has reported Assets Average for 10 years, with the latest figure at $101.7 million in Q4 2025.

• For the quarter ending Q4 2025, Assets Average fell 9.85% year-over-year to $101.7 million; the trailing twelve-month figure through Dec 2025 stood at $101.7 million (down 9.85% YoY), and the FY2025 full-year result was $113.5 million, up 18.47% from the prior year.
• Assets Average for Q4 2025 stood at $101.7 million, down from $114.5 million in the prior quarter.
• The five-year high for Assets Average was $132.9 million in Q1 2025, with the low at $40.1 million in Q2 2022.
• Average Assets Average over 5 years is $77.4 million, with a median of $71.4 million recorded in 2023.
• Year-over-year, Assets Average plunged 50.1% in 2022 and jumped 183.1% in 2025.
• Tracing PLSE's Assets Average over 5 years: stood at $63.2 million in 2021, then jumped by 30.99% to $82.7 million in 2022, then retreated by 24.39% to $62.5 million in 2023, then jumped by 80.26% to $112.8 million in 2024, then decreased by 9.85% to $101.7 million in 2025.
• The last three Assets Average figures came in at $101.7 million (Q4 2025), $114.5 million (Q3 2025), and $126.8 million (Q2 2025), per Business Quant data.

Peer Comparison